New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
12:20 EDTFIO, ISIS, FTNT, CRUS, TPXStocks with increasing option volume; ISIS TPX FTNT FIO CRUS
News For ISIS;TPX;FTNT;FIO;CRUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 7, 2015
07:42 EDTTPXTempur Sealy new product line selling well, says Wedbush
Subscribe for More Information
07:31 EDTFTNTFortinet checks very positive, says Oppenheimer
After conducting checks, Oppenheimer believes that Fortinet enjoyed a "crescendo" at the end of the quarter. The firm continues to believe that the company is benefiting from strong demand for its high-end appliances, strong bookings, and strong demand for its mid-level products. The firm raised its price target on the name to $50 from $46 and recommends aggressively buying the shares ahead of the company's Q2 results.
July 6, 2015
11:24 EDTFTNTCowen shakes up cybersecurity ratings, cuts Fortinet to sell
Subscribe for More Information
10:01 EDTFTNTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:15 EDTFTNTOn The Fly: Pre-market Movers
Subscribe for More Information
07:05 EDTISISAkcea Therapeutica receives orphan drug designatoin from FDA for Volanesorsen
Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, announced that the FDA has granted Orphan Drug Designation to volanesorsen for the treatment of patients with Familial Chylomicronemia Syndrome. FCS is a rare genetic disease characterized by extremely high triglyceride levels and risk of pancreatitis. In a Phase 2 study published in the NEJM in December 2014, patients with FCS treated with volanesorsen achieved substantial reductions in apoC-III, triglycerides, chylomicrons and apoC-III-associated very low density lipoprotein-cholesterol particles.1 Akcea is currently conducting an international multi-center, randomized, double-blind, placebo-controlled Phase 3 study in patients with FCS.
06:23 EDTFTNTFortinet downgraded to Underperform from Market Perform at Cowen
Subscribe for More Information
July 2, 2015
07:45 EDTTPXTempur Sealy price target raised to $75 from $65 at Stifel
Subscribe for More Information
July 1, 2015
14:49 EDTFTNTTrump Hotels becomes latest victim of credit card data breach, Krebs says
Subscribe for More Information
June 26, 2015
10:56 EDTFTNTBarclays calls Fortinet, Palo Alto best bets in cybersecurity sector
Subscribe for More Information
10:00 EDTFTNTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:41 EDTFTNTFireEye downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
05:35 EDTFTNTFortinet initiated with an Overweight at Barclays
Target $50.
June 24, 2015
12:06 EDTFTNTU.S. data hack larger than previously disclosed, WSJ reports
Office of Personnel Management Director Katherine Archuleta said in a statement today to the House Oversight Committee that her agency is investigating whether up to 18M unique Social Security numbers were stolen as part of the previously disclosed cyberattack, Wall Street Journal reports. The hack is being defined as two distinct breaches, and the larger than previously thought numbers are preliminary and not verified, the Journal adds. Publicly traded companies in the cybersecurity space include Barracuda Networks (CUDA), Check Point (CHKP), F5 Networks (FFIV), FireEye (FEYE), Fortinet (FTNT), Imperva (IMPV), Palo Alto (PANW), Proofpoint (PFPT), Qualys (QLYS) and Symantec (SYMC). Reference Link
10:00 EDTFTNTOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Autoliv (ALV) downgraded to Sell from Neutral at Goldman... Catamaran (CTRX) downgraded to Neutral from Buy at UBS... Citi (C) downgraded to Hold from Buy at Deutsche Bank... Esperion (ESPR) downgraded to Neutral from Outperform at Credit Suisse... Fortinet (FTNT) downgraded to Neutral from Buy at Citi... General Motors (GM) downgraded to Neutral from Buy at Goldman... Goldman Sachs (GS) downgraded to Hold from Buy at Deutsche Bank... IBERIABANK (IBKC) downgraded to Neutral from Outperform at Baird... Independent Bank (INDB) downgraded to Underperform from Neutral at Baird... Inphi (IPHI) downgraded to Market Perform from Outperform at Northland... MoneyGram (MGI) downgraded to Neutral from Outperform at Macquarie... Sensata (ST) downgraded to Hold from Buy at Cross Research... Teradyne (TER) downgraded to Buy from Conviction Buy at Goldman... Alcobra (ADHD) downgraded to Hold from Speculative Buy at WBB Securities.
09:10 EDTFTNTOn The Fly: Pre-market Movers
Subscribe for More Information
08:54 EDTFTNTFortinet downgraded to Neutral from Buy at Citi
Subscribe for More Information
06:53 EDTFTNTFortinet downgraded to Neutral from Outperform at Baird
Subscribe for More Information
June 23, 2015
18:04 EDTISISIsis Pharma granted FDA orphan status for treatment of familial chylomicronemia
Subscribe for More Information
08:58 EDTISISIsis Pharmaceuticals shares not reflecting SMA data, says Needham
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use